Filing Flows › Health Care › Charlie's Holdings (CHUC)
Charlie's Holdings (CHUC) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 17, 2026 · Charlie's Holdings (CHUC) Q2 2026 earnings results →
Q2 2026 Revenue up 116% year over year to $3.8M · 44¢ of every $1 of revenue lost · operating margin -32.5%
Charlie's Holdings made $3.8M in Q2 2026 (+116% Y/Y). Operating margin -32.5%, net loss $1.7M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 17, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $3.8M in Q2 2026, up 116% year over year and down 21% from the previous quarter.
Gross margin was 29.4%, up 1.8 points from Q2 2025. Operating costs exceeded revenue by $1.2M, an operating margin of -32.5%. Operating expenses grew 63% against revenue growth of 116%. The fastest-growing cost line was Sales & marketing (+378%). The quarter ended with a net loss of $1.7M, wider than the previous quarter's $1.1M loss.
Operating cash flow was −$383K. Non-cash charges added back $5K of depreciation and amortization and $18K of share-based compensation. Working capital and other items added $1.3M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 17, 2026 | $3.8M | +116% | -32.5% | −$1.7M | −$383K |
| Q1 2026 | 10-Q | May 20, 2026 | $4.8M | +204% | -20.3% | −$1.1M | −$1.1M |
| Q4 2025 | 10-K | Apr 1, 2026 | $9.0M | +758% | -1.4% | $131K | $394K |
| Q3 2025 | 10-Q | Nov 19, 2025 | $7.1M | +336% | -4.8% | $624K | −$12.3M |
| Q2 2025 | 10-Q | Aug 21, 2025 | $2.5M | +24% | -34.5% | $5.0M | −$2.7M |
| Q1 2025 | 10-Q | Jun 27, 2025 | $2.3M | -24% | -35.8% | −$1.2M | −$409K |
| Q4 2024 | 10-K | May 29, 2025 | $1.8M | -68% | -42.3% | −$1.1M | −$377K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Charlie's Holdings
Charlie’s Holdings, Inc., a Nevada corporation, together with its wholly owned subsidiaries (collectively, the “ Company ”, “ we ”), formulates, markets and distributes premium, non-combustible nicotine-related products and alternative alkaloid vapor products. The Company’s products are produced through contract manufacturers for sale through select distributors, specialty retailers, and third-party online resellers throughout the United States, and in select international markets. Charlie’s Chalk Dust, LLC (“ Charlie ’ s ” or “ CCD ”), is the Company’s wholly owned subsidiary which produces and sells nicotine-based and alternative alkaloid vapor products.
In its own words, from its 10-Q, filed Aug 17, 2026.
Charlie's Holdings against its Medicinal Chemicals & Botanical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +116% against the peers' median +11%. Operating margin: -32.5% against the peers' median 0.8%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| CHUC Charlie's Holdings | Q2 2026 | $3.8M | +116% | -32.5% |
| CURLF Curaleaf Holdings | Q3 2026 | $353M | +11% | 0.8% |
| TLRY Tilray Brands | Q1 FY27 | $257M | +23% | -9.4% |
| TRLV Trulieve Cannabis | Q3 2026 | $230M | -20% | 18.5% |
| USNA Usana Health Sciences | Q2 2026 | $223M | -5% | -9.0% |
| AAWH Ascend Wellness Holdings | Q2 2026 | $126M | -0.9% | 4.2% |
| CRON Cronos Group | Q3 2026 | $83.9M | +72% | 10.8% |
| CGC Canopy Growth | Q2 FY27 | $71.1M | +20% | -23.1% |
| JUSH Jushi Holdings | Q3 2026 | $70.5M | +7% | 5.0% |
Source: Charlie's Holdings 10-Q on SEC EDGAR · CIK 1134765 · Medicinal Chemicals & Botanical Products
More on CHUC
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results